April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
April 5, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is researching how different rates of cerebral small vessel disease and genetic differences contribute to higher rates of Alzheimer's disease and related dementias in non-Hispanic Black populations compared to non-Hispanic white patients.
April 1, 2022
Medscape featured the University of Cincinnati's Dr. Donald Gilbert in an article about a new drug that has been shown to be effective in reducing tics in Tourette syndrome patients while causing less side effects.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
March 28, 2022
The University of Cincinnati's Daniel Woo and colleagues recently published a paper in JAMA revealing new insights on how different risk factors following intracerebral hemorrhages can affect patient outcomes.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 23, 2022
The University of Cincinnati's Michael Hegener, PharmD, was featured in a HuffPost article about different health issues pharmacists can help patients with beyond filling prescriptions.
March 21, 2022
The University of Cincinnati's Jordan Kharofa, MD, joined 55KRC's Simply Medicine radio show and podcast to discuss Colorectal Cancer Awareness Month.
March 17, 2022
MSN featured University of Cincinnati research led by Alberto Espay and Luca Marsili that is expanding genetic testing of rare movement disorders for Chilean patients.
March 17, 2022
WVXU featured the University of Cincinnati's Dr. Tahir Latif in a news story about how immunocompromised people are navigating life with most mask guidelines being lifted.